Assertio has not been acquired by another entity. It functions as an independent, publicly traded commercial pharmaceutical company. Rather than being a target of acquisition, Assertio itself has acted as an active corporate acquirer, successfully purchasing and integrating other pharmaceutical enterprises—such as Spectrum Pharmaceuticals—to expand its commercial product revenue streams.